These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37951476)
1. Nanomedicine approaches against SARS-CoV-2 and variants. Zhang H; Liu Y; Liu Z J Control Release; 2024 Jan; 365():101-111. PubMed ID: 37951476 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies. Gong W; Parkkila S; Wu X; Aspatwar A Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216 [TBL] [Abstract][Full Text] [Related]
3. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022). Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339 [TBL] [Abstract][Full Text] [Related]
4. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic. Chadha J; Khullar L; Mittal N Environ Microbiol; 2022 Jun; 24(6):2615-2629. PubMed ID: 34320263 [TBL] [Abstract][Full Text] [Related]
5. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Hasanzadeh A; Alamdaran M; Ahmadi S; Nourizadeh H; Bagherzadeh MA; Mofazzal Jahromi MA; Simon P; Karimi M; Hamblin MR J Control Release; 2021 Aug; 336():354-374. PubMed ID: 34175366 [TBL] [Abstract][Full Text] [Related]
6. Biomimetic Nanotechnology for SARS-CoV-2 Treatment. Li S; Liu X; Liu G; Liu C Viruses; 2023 Feb; 15(3):. PubMed ID: 36992304 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200 [TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-based strategies against SARS-CoV-2 variants. Huang X; Kon E; Han X; Zhang X; Kong N; Mitchell MJ; Peer D; Tao W Nat Nanotechnol; 2022 Oct; 17(10):1027-1037. PubMed ID: 35982317 [TBL] [Abstract][Full Text] [Related]
9. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants. Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM Elife; 2022 Aug; 11():. PubMed ID: 36004719 [TBL] [Abstract][Full Text] [Related]
10. Next-generation treatments: Immunotherapy and advanced therapies for COVID-19. Arevalo-Romero JA; Chingaté-López SM; Camacho BA; Alméciga-Díaz CJ; Ramirez-Segura CA Heliyon; 2024 Mar; 10(5):e26423. PubMed ID: 38434363 [TBL] [Abstract][Full Text] [Related]
11. Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2. Mufamadi MS; Ngoepe MP; Nobela O; Maluleke N; Phorah B; Methula B; Maseko T; Masebe DI; Mufhandu HT; Katata-Seru LM Biomed Res Int; 2023; 2023():4588659. PubMed ID: 37181817 [TBL] [Abstract][Full Text] [Related]
12. COVID-19: Progress in diagnostics, therapy and vaccination. Liu X; Liu C; Liu G; Luo W; Xia N Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022 [TBL] [Abstract][Full Text] [Related]
13. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference. Mukherjee S; Ray SK Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456 [TBL] [Abstract][Full Text] [Related]
14. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein. Yao Z; Zhang L; Duan Y; Tang X; Lu J J Infect; 2024 Mar; 88(3):106121. PubMed ID: 38367704 [TBL] [Abstract][Full Text] [Related]
15. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
16. Dynamic Evolution of SARS-CoV-2 in West Sumatra: Analyzing S Gene Mutations Across Variants and Their Impact on Public Health and Vaccine Strategies. Linosefa L; Hasmiwati H; Jamsari J; Putra AE Pak J Biol Sci; 2024 Mar; 27(4):182-189. PubMed ID: 38812109 [TBL] [Abstract][Full Text] [Related]
17. Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2. Ross KA; Kelly S; Phadke KS; Peroutka-Bigus N; Fasina O; Siddoway A; Mallapragada SK; Wannemuehler MJ; Bellaire BH; Narasimhan B Acta Biomater; 2024 Jul; 183():318-329. PubMed ID: 38844193 [TBL] [Abstract][Full Text] [Related]
18. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Abd Ellah NH; Gad SF; Muhammad K; E Batiha G; Hetta HF Nanomedicine (Lond); 2020 Sep; 15(21):2085-2102. PubMed ID: 32723142 [TBL] [Abstract][Full Text] [Related]
19. Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe. Thakur V; Bhola S; Thakur P; Patel SKS; Kulshrestha S; Ratho RK; Kumar P Infection; 2022 Apr; 50(2):309-325. PubMed ID: 34914036 [TBL] [Abstract][Full Text] [Related]